Analysis of the Global Fibrinogen Market and Product Pipeline

Analysis of the Global Fibrinogen Market and Product Pipeline

Launch of Topical and Ready-to-Use Fibrin Sealants Impetus to Growth

RELEASE DATE
08-Dec-2015
REGION
Global
Research Code: MB93-01-00-00-00
SKU: LS00163-GL-MR_17139

$6,000.00

Special Price $4,500.00 save 25 %

In stock
SKU
LS00163-GL-MR_17139

$6,000.00

$4,500.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed and pipeline products are segmented based on their therapeutic uses, namely, deficiency therapy and operative care. An elaborate discussion on clinical trial timelines and results, along with historical and projected launch timelines, has been provided. The study also discusses key companies such as CSL Behring, LFB, Baxter Healthcare, Takeda, Grifols, and Octapharma.

Table of Contents

Executive Summary—Key Findings

Executive Summary—Key Findings (continued)

Key Trends

Companies to Watch

Methodology and Scope

Market Overview—Introduction

Market Overview—Blood Plasma Production

Market Segmentation

Blood Plasma Market Share

Fibrinogen Production

Revenue Forecast

Revenue Forecast Discussion

Supply Chain and Distribution Network

Supply Chain and Distribution Network (continued)

Competitive Landscape—Marketed and Pipeline Products

Competitive Landscape Overview

Marketed Products—Deficiency and Other Therapies

Pipeline Products—Deficiency and Other Therapies

Marketed Products—Operative Care

Marketed Products—Operative Care (continued)

Pipeline Products—Operative Care

Fibrinogen Market—Major On-going/Recently Completed Clinical Trials

Fibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)

Fibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)

Summary of Key Products to Watch

Summary of Key Products to Watch (continued)

Timeline of Key Events—Launch of Products

Product Dashboard—Haemocomplettan/RiaSTAP (CSL Behring)

Product Dashboard—Clottafact (LFB)

Product Dashboard—Octafibrin (Octapharma)

Product Dashboard—Artiss (Baxter Healthcare)

Product Dashboard—Evarrest (Ethicon)

Product Dashboard—Raplixa (The Medicines Company)

Product Dashboard—FS Grifols (Grifols)

Conclusions

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Related Research
The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed and pipeline products are segmented based on their therapeutic uses, namely, deficiency therapy and operative care. An elaborate discussion on clinical trial timelines and results, along with historical and projected launch timelines, has been provided. The study also discusses key companies such as CSL Behring, LFB, Baxter Healthcare, Takeda, Grifols, and Octapharma.
More Information
No Index No
Podcast No
Author Sriram Radhakrishnan
WIP Number MB93-01-00-00-00
Is Prebook No